Solana Co — Director's Dealing 2019

Dec 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-12-07

Reporting Person: Peng Huaizheng (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-07	Stock Option (Right to Buy)	$4.48	D	10000	Disposed	2020-12-31	Class A Common Stock (10000)	Direct
2019-12-07	Stock Option (Right to Buy)	$4.48	A	10000	Acquired	2025-12-31	Class A Common Stock (10000)	Direct
2019-12-07	Stock Option (Right to Buy)	$5.35	D	15000	Disposed	2020-07-13	Class A Common Stock (15000)	Direct
2019-12-07	Stock Option (Right to Buy)	$5.35	A	15000	Acquired	2026-07-13	Class A Common Stock (15000)	Direct

Footnotes

F1: These two reported transactions involved an amendment of an outstanding option originally granted on December 31, 2015 resulting in the deemed cancellation of the December 31, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2: Immediately exercisable.

F3: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.